Medexus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	6.52	23.97	5.26	13.07	10.02
Cash & Short-Term Investments	6.52	23.97	5.26	13.07	10.02
Cash Growth	-72.79%	356.19%	-59.79%	30.45%	-46.44%
Accounts Receivable	14.78	13.17	23.87	21.97	13.39
Other Receivables	0.08	0.14	0.16	0.41	1.02
Receivables	14.86	13.31	24.03	22.38	14.41
Inventory	36.87	39.82	36.72	22.85	21.35
Prepaid Expenses	5.09	3.1	4.19	12.38	2.06
Other Current Assets	0.45	0.38	2.3	2.3	1.28
Total Current Assets	63.78	80.57	72.5	72.97	49.11
Property, Plant & Equipment	0.42	0.69	0.78	0.9	1.22
Goodwill	10.14	10	10.28	10.28	10.69
Other Intangible Assets	62.34	71.6	64.14	70.37	76.57
Long-Term Deferred Tax Assets	10.6	8.98	8.04	6.81	-
Other Long-Term Assets	-	-	-	-	1.64
Total Assets	147.28	171.84	155.73	161.33	139.23
Accounts Payable	8.22	5.73	7.75	10.16	12.05
Accrued Expenses	38.33	35.42	35.48	23.26	17.13
Current Portion of Long-Term Debt	2.21	36.79	15.74	42.71	15.05
Current Portion of Leases	-	0.19	-	-	-
Current Income Taxes Payable	2.12	1.37	1.32	1.18	0.03
Other Current Liabilities	2.7	17.81	5.94	6.19	3.86
Total Current Liabilities	53.58	97.31	66.23	83.5	48.11
Long-Term Debt	19.79	-	33.61	26.78	39.03
Long-Term Leases	0.26	0.2	0.54	0.6	0.78
Long-Term Deferred Tax Liabilities	-	-	-	-	1.52
Other Long-Term Liabilities	24.66	22.19	25.03	28.01	31.99
Total Liabilities	98.29	119.7	125.41	138.88	121.43
Common Stock	95.56	96.1	76.39	69.01	68.69
Additional Paid-In Capital	11.72	12.01	12.01	11.31	10.38
Retained Earnings	-64.39	-62	-64.24	-64.03	-65.25
Comprehensive Income & Other	6.1	6.03	6.17	6.16	3.97
Shareholders' Equity	48.99	52.14	30.32	22.45	17.79
Total Liabilities & Equity	147.28	171.84	155.73	161.33	139.23
Total Debt	22.26	37.18	49.9	70.08	54.86
Net Cash (Debt)	-15.74	-13.21	-44.64	-57.01	-44.84
Net Cash Per Share	-0.49	-0.50	-2.00	-2.78	-2.26
Filing Date Shares Outstanding	31.66	32.26	24.46	20.25	19.95
Total Common Shares Outstanding	32.03	32.26	24.46	20.18	19.95
Working Capital	10.2	-16.74	6.27	-10.53	1
Book Value Per Share	1.53	1.62	1.24	1.11	0.89
Tangible Book Value	-23.49	-29.46	-44.09	-58.21	-69.46
Tangible Book Value Per Share	-0.73	-0.91	-1.80	-2.88	-3.48
Machinery	1.12	1.26	1.12	1.07	1.06